William Blair & Company
GMED icon

William Blair & Company’s Globus Medical GMED Stock Holding History

William Blair & Company’s Portfolio GMED Stock Details GMED Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$599K Buy
6,948
+88
+1% +$7.9K ﹤0.01% 1091
2025
Q4 		$599K Sell
6,860
-128
-2% -$9.71K ﹤0.01% 1079
2025
Q3 		$400K Sell
6,988
-139
-2% -$8K ﹤0.01% 1192
2025
Q2 		$421K Hold
7,127
– – ﹤0.01% 1145
2025
Q1 		$522K Sell
7,127
-37
-0.5% -$3.06K ﹤0.01% 1074
2024
Q4 		$593K Sell
7,164
-4,160
-37% -$328K ﹤0.01% 1048
2024
Q3 		$810K Sell
11,324
-1,567
-12% -$111K ﹤0.01% 964
2024
Q2 		$883K Sell
12,891
-702
-5% -$41.9K ﹤0.01% 921
2024
Q1 		$729K Sell
13,593
-1,558
-10% -$83.8K ﹤0.01% 980
2023
Q4 		$807K Buy
15,151
+175
+1% +$8.53K ﹤0.01% 928
2023
Q3 		$744K Buy
14,976
+6,240
+71% +$349K ﹤0.01% 934
2023
Q2 		$520K Buy
8,736
+651
+8% +$37.1K ﹤0.01% 1041
2023
Q1 		$458K Sell
8,085
-3,415
-30% -$219K ﹤0.01% 1078
2022
Q4 		$854K Buy
11,500
+1,906
+20% +$130K ﹤0.01% 879
2022
Q3 		$572K Buy
9,594
+42
+0.4% +$2.53K ﹤0.01% 993
2022
Q2 		$536K Sell
9,552
-3,926
-29% -$258K ﹤0.01% 1040
2022
Q1 		$994K Sell
13,478
-1,390
-9% -$96.6K ﹤0.01% 926
2021
Q4 		$1.07M Sell
14,868
-810
-5% -$58.8K ﹤0.01% 932
2021
Q3 		$1.2M Sell
15,678
-2,450
-14% -$197K ﹤0.01% 864
2021
Q2 		$1.41M Buy
18,128
+1,905
+12% +$135K ﹤0.01% 812
2021
Q1 		$1M Sell
16,223
-105
-0.6% -$6.65K ﹤0.01% 895
2020
Q4 		$1.06M Buy
16,328
+1,066
+7% +$61.3K ﹤0.01% 827
2020
Q3 		$756K Buy
15,262
+1,400
+10% +$72.2K ﹤0.01% 844
2020
Q2 		$661K Buy
13,862
+2,543
+22% +$123K ﹤0.01% 861
2020
Q1 		$481K Sell
11,319
-375
-3% -$18.5K ﹤0.01% 880
2019
Q4 		$689K Buy
11,694
+214
+2% +$11.6K ﹤0.01% 885
2019
Q3 		$587K Hold
11,480
– – ﹤0.01% 902
2019
Q2 		$486K Hold
11,480
– – ﹤0.01% 987
2019
Q1 		$567K Sell
11,480
-900
-7% -$40.7K ﹤0.01% 922
2018
Q4 		$536K Hold
12,380
– – ﹤0.01% 886
2018
Q3 		$703K Hold
12,380
– – ﹤0.01% 848
2018
Q2 		$625K Hold
12,380
– – ﹤0.01% 872
2018
Q1 		$617K Hold
12,380
– – ﹤0.01% 853
2017
Q4 		$509K Hold
12,380
– – ﹤0.01% 961
2017
Q3 		$368K Buy
+12,380
New +$378K ﹤0.01% 1037
2016
Q4 		– Sell
-71,035
Closed -$1.6M – 1429
2016
Q3 		$1.6M Sell
71,035
-960
-1% -$22.6K 0.01% 538
2016
Q2 		$1.72M Sell
71,995
-81,054
-53% -$1.94M 0.02% 497
2016
Q1 		$3.63M Sell
153,049
-16,597
-10% -$406K 0.03% 332
2015
Q4 		$4.72M Sell
169,646
-5,087
-3% -$128K 0.04% 303
2015
Q3 		$3.61M Buy
174,733
+21,998
+14% +$557K 0.03% 379
2015
Q2 		$3.92M Sell
152,735
-5,420
-3% -$137K 0.01% 1133
2015
Q1 		$3.99M Sell
158,155
-445
-0.3% -$10.8K 0.01% 1104
2014
Q4 		$3.77M Sell
158,600
-8,766
-5% -$194K 0.01% 1111
2014
Q3 		$3.29M Sell
167,366
-590,424
-78% -$12.1M 0.01% 1120
2014
Q2 		$18.1M Sell
757,790
-37,253
-5% -$899K 0.03% 603
2014
Q1 		$21.1M Sell
795,043
-227,054
-22% -$5.4M 0.04% 531
2013
Q4 		$20.6M Buy
1,022,097
+156,130
+18% +$2.9M 0.03% 531
2013
Q3 		$15.1M Sell
865,967
-21,220
-2% -$367K 0.03% 594
2013
Q2 		$15M Buy
+887,187
New +$13.7M 0.03% 566

Other funds holding GMED

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
SC
Sculptor Capital New York $9.61B AUM 27.5% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Bank of Montreal
Bank of Montreal Toronto, Ontario, Canada $269B AUM 31.4% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

William Blair & Company's GMED Position: Q1 2026 in Review

William Blair & Company increased its Globus Medical (GMED) stake by 1.3% in Q1 2026, buying an estimated $7.9K and bringing the position to 6,948 shares worth $599K. The position accounts for ﹤0.01% of the portfolio, ranked #1091.

William Blair & Company first reported a position in GMED in Q2 2013 and has held it in 49 quarters since. The position peaked at $21.1M in Q1 2014. 605 funds tracked by Wall St. Rank hold GMED as of Q1 2026.

  • William Blair & Company held 6,948 shares of Globus Medical worth $599K as of Q1 2026.
  • William Blair & Company bought 88 Globus Medical shares in Q1 2026, an estimated $7.9K.
  • Globus Medical made up ﹤0.01% of William Blair & Company's portfolio in Q1 2026, its #1091 holding.
  • William Blair & Company first reported a position in Globus Medical in Q2 2013 and has held it in 49 quarters since.
  • William Blair & Company's Globus Medical position peaked at $21.1M in Q1 2014.
  • 605 funds tracked by Wall St. Rank held Globus Medical as of Q1 2026.

Based on William Blair & Company's 13F filing for Q1 2026, filed 8 May 2026.